Showing 2211-2220 of 2527 results for "".
- ECPs Can Now Access Online Training to Certify to Prescribe CooperVision’s Brilliant Futures Myopia Management Programhttps://modernod.com/news/ecps-can-now-access-online-training-to-certify-to-prescribe-coopervisions-brilliant-futures-myopia-management-program/2477762/This month, CooperVision unveiled an online training curriculum so eye care professionals (ECPs) can certify to prescribe the Brilliant Futures Myopia Management Program featuring MiSight 1 day contact lenses. CooperVision will continue outreach to ECPs who have experience with pediatric populati
- 1-800 Contacts Launches Online Glasses Lens Replacement Brand, Boomerang Lenseshttps://modernod.com/news/covid-19-weekly-review/2477734/1-800 Contacts unveiled Boomerang, an online lens replacement service that provides new lenses for consumers to put in their current glasses without having to visit an eye doctor or optical shop. As the current health crisis began to unfold, and eyecare providers and optical shops began f
- jCyte Enters Into Ex-US Licensing and Commercialization Agreement for jCell Therapy With Santenhttps://modernod.com/news/jcyte-enters-into-ex-us-licensing-and-commercialization-agreement-for-jcell-therapy-with-santen/2477727/jCyte Inc. announced it has entered into a licensing agreement with Santen Pharmaceutical to develop and commercialize its first-in-class, investigational therapy, jCell, outside the United States, in regions including Europe, Asia, and Japan. Under the terms of the licensing agreement, jC
- FDA Increases Oversight, Requirements for COVID-19 Antibody Testshttps://modernod.com/news/fda-increases-oversight-requirements-for-covid-19-antibody-tests/2477723/After allowing unreviewed antibody tests to pervade the U.S. market for weeks, the FDA is closing its open-door policy for coronavirus blood serology tests—bringing their oversight more in line with the molecular diagnostics used to confirm active cases of COVID-19, according to a Fierc
- Bausch + Lomb Licenses Exclusive Rights To a Biosimilar Candidate for Lucentis (Ranibizumab) in the US and Canadahttps://modernod.com/news/bausch-lomb-licenses-exclusive-rights-to-a-biosimilar-candidate-for-lucentis-ranibizumab-in-the-us-and-canada/2477718/Bausch + Lomb has entered into an exclusive licensing agreement with STADA Arzneimittel AG and its development partner, Xbrane Biopharma AB, a Nordic biosimilar developer, to develop and commercialize a biosimilar candidate to Lucentis (ranibizumab) in the United States and Canada. The companies
- UK Surpasses Italy In Recorded Coronavirus Deaths, Now Leads Europe In Fatalitieshttps://modernod.com/news/uk-surpasses-italy-in-recorded-coronavirus-deaths-now-leads-europe-in-fatalities/2477715/Over 32,000 people have died from the new coronavirus in the United Kingdom, according to the Office for National Statistics, marking the first time in the pandemic that it has led Europe in the number of deaths, according to an NPR
- Pfizer Begins Human Testing for Experimental Coronavirus Vaccine In the UShttps://modernod.com/news/pfizer-begins-human-testing-for-experimental-coronavirus-vaccine-in-the-us/2477710/Pfizer said Tuesday it has begun testing an experimental vaccine to combat the coronavirus in the United States. The U.S.-based pharmaceutical giant, which is working alongside German drugmaker BioNTech, said the first human participants in the United States have been dosed with the potential vac
- AI-Supported Test Can Detect Glaucoma Progression 18 Months Earlierhttps://modernod.com/news/ai-supported-test-can-detect-glaucoma-progression-18-months-earlier/2477706/A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a clinical trial sponsored by the University College London (UCL). The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate cli
- More Than 1 Million People Have Recovered From COVID-19 Worldwidehttps://modernod.com/news/more-than-1-million-people-have-recovered-from-covid-19-worldwide/2477691/More than 1 million people around the world have recovered from COVID-19, according to data collected by Johns Hopkins University, as
- An Imaging Method To Help Us See Behind Our Eyeshttps://modernod.com/news/an-imaging-method-to-help-us-see-behind-our-eyes/2477684/The choroidal and retrobulbar blood vessels sit at the deep region of our eyes, supplying oxygen and nutrients to the retina. They are vital to our vision and the health and structure of our eyes. However, we don’t understand these important blood vessels as well as we should, because current ima